BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 18237867)

  • 21. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
    Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histologic and serum risk markers for noncardia early gastric cancer.
    Shiotani A; Iishi H; Uedo N; Kumamoto M; Nakae Y; Ishiguro S; Tatsuta M; Graham DY
    Int J Cancer; 2005 Jun; 115(3):463-9. PubMed ID: 15688378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
    Storskrubb T; Aro P; Ronkainen J; Sipponen P; Nyhlin H; Talley NJ; Engstrand L; Stolte M; Vieth M; Walker M; Agréus L
    Scand J Gastroenterol; 2008; 43(12):1448-55. PubMed ID: 18663663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
    Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
    Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
    Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
    Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.
    Nasrollahzadeh D; Aghcheli K; Sotoudeh M; Shakeri R; Persson EC; Islami F; Kamangar F; Abnet CC; Boffetta P; Engstrand L; Dawsey SM; Malekzadeh R; Ye W
    PLoS One; 2011; 6(10):e26957. PubMed ID: 22066020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morpho-functional comparisons in Helicobacter pylori-associated chronic atrophic gastritis.
    Pasechnikov VD; Chukov SZ; Kotelevets SM; Chabannaya TA
    Rocz Akad Med Bialymst; 2005; 50():183-7. PubMed ID: 16358962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M; Valle J; Härkönen M; Maaroos HI; Peetsalu A
    Hepatogastroenterology; 2005; 52(63):785-91. PubMed ID: 15966205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
    Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
    Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
    Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
    Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice.
    de Vries AC; Haringsma J; de Vries RA; ter Borg F; Nagtzaam NM; Steyerberg EW; van Dekken H; Kuipers EJ
    Gastrointest Endosc; 2009 Jul; 70(1):18-25. PubMed ID: 19249770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen.
    Wu KC; Li HT; Qiao TD; Li CN; Ji WS; Tian FQ; Wang X; Wang BL; Miao JY; Ding J; Fan DM
    Chin J Dig Dis; 2004; 5(1):22-7. PubMed ID: 15612668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.